1. Differential impacts of trail and ultra-trail running on cytokine profiles: An observational study
- Author
-
Sarah Skinner, Clément Foschia, Mélanie Robert, Paul Robach, Emeric Stauffer, Camille Boisson, Léonard Féasson, Guillaume Y. Millet, Philippe Connes, Agnès Cibiel, and Elie Nader
- Subjects
Inflammation ,0301 basic medicine ,Physiology ,medicine.medical_treatment ,Marathon Running ,030229 sport sciences ,Hematology ,Biology ,Running ,03 medical and health sciences ,Race (biology) ,030104 developmental biology ,0302 clinical medicine ,Cytokine ,Physiology (medical) ,Immunology ,Leukocytes ,Physical Endurance ,medicine ,Cytokines ,Humans ,Observational study ,Cardiology and Cardiovascular Medicine ,Increased Cytokine Production - Abstract
BACKGROUND: Endurance running events are known to cause inflammation and result in increased cytokine production. However, the effects of ultramarathons on cytokine profiles are not well characterized. OBJECTIVE: The aim of this study was to describe and compare the effects of a trail (40 km) race and an ultra-trail (171 km) race on leukocyte concentrations and cytokine profiles. METHODS: The study was conducted during the Ultra-Trail du Mont Blanc® ultra-marathon running event, and included 11 runners who completed the 40 km trail run and 12 runners who completed the 171 km ultra-trail. Blood samples were taken before and after the races. RESULTS: Leukocyte concentrations significantly increased after both races. Circulating levels of IL-6, IL-1β, MCP-1, and IFN-γ were significantly higher after the longer race compared to the shorter race. Furthermore, while both races resulted in significant increases in IL-6 and IL-8, only the longer race resulted in significant increases in MIP-1β, IL-7, IL-17a, and IL-4. CONCLUSIONS: These results illustrate that a 171 km ultra-trail race results in greater modulations in cytokine profiles than a traditional trail race.
- Published
- 2021
- Full Text
- View/download PDF